Cedric Komar is the CEO of Ictyopharma, CRO specialized in the development of vaccines for the tilapia industry. He is a veterinarian with more than 15 years of experience in the field of aquatic animal health and has worked in a large number of countries including USA, Malta, Israel, Mexico, Singapore, Vietnam and France. He trained in France and at the Institute of Aquaculture in Scotland. He also has an MBA from the Nanyang University of Singapore with a strong focus on business development in the APAC region. Before co-founding Ictyopharma 4 years ago, Cedric has held technical and management positions for a leading pharmaceutical company, and was responsible for AAH business development in the APAC region. He is married, has 2 boys of 5 and 7 years old and is a yoga practitioner.